Radiological and pathological assessment of response to neoadjuvant CDK4/6 inhibitor and endocrine treatments in a real-life setting—initial results

BACKGROUND: Neoadjuvant endocrine therapy is an alternative to neoadjuvant chemotherapy in women with inoperable luminal-like breast cancers. Neoadjuvant cyclin-dependent kinase 4/6 inhibitor treatment combined with endocrine treatment (CDK4/6I + E) is interesting given the combination’s utility in...

Descripción completa

Detalles Bibliográficos
Autores principales: Moisander, Mikko, Salminen, Annukka, Jukkola, Arja, Sassi, Antti, Tervo, Maija, Mäenpää, Niina, Tiainen, Leena, Rinta-Kiikka, Irina, Tolonen, Teemu, Arponen, Otso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377317/
https://www.ncbi.nlm.nih.gov/pubmed/34422318
http://dx.doi.org/10.1177/20584601211030660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377317/
https://www.ncbi.nlm.nih.gov/pubmed/34422318
http://dx.doi.org/10.1177/20584601211030660

Ejemplares similares